News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA Probes Risks of HIV, Prostate, Other Drugs; Abbott Laboratories (ABT)' Kaletra, GlaxoSmithKline (GSK)'s Avodart on List


5/4/2010 7:08:23 AM

Reuters -- U.S. regulators are investigating potential risks from Abbott Laboratories Inc's (ABT.N) HIV drug Kaletra, GlaxoSmithKline Plc's (GSK.L) prostate drug Avodart and other medicines.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES